Validation of Calprotectin As a Novel Biomarker For The Diagnosis of Pleural Effusion: a Multicentre Trial

Discriminating between malignant pleural effusion (MPE) and benign pleural effusion (BPE) remains difficult. Thus, novel and efficient biomarkers are required for the diagnosis of pleural effusion (PE). The aim of this study was to validate calprotectin as a diagnostic biomarker of PE in clinical se...

Descripción completa

Detalles Bibliográficos
Autores principales: Botana-Rial, Maribel, Vázquez-Iglesias, Lorena, Casado-Rey, Pedro, Cadena, María Páez de la, Andrade-Olivié, María Amalia, Abal-Arca, José, García-Nimo, Laura, Ferreiro-Fernández, Lucía, Valdés-Cuadrado, Luis, San-José, María Esther, Rodríguez-Berrocal, Francisco Javier, Fernández-Villar, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7105479/
https://www.ncbi.nlm.nih.gov/pubmed/32231227
http://dx.doi.org/10.1038/s41598-020-62388-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7105479/
https://www.ncbi.nlm.nih.gov/pubmed/32231227
http://dx.doi.org/10.1038/s41598-020-62388-y

Ejemplares similares